Zan Zeng

Zan Zeng

Auto-generated profile, based on publicly available information

Zan Zeng

Department of Vascular Surgery, the Third Affiliated Hospital, Naval Medical University, Shanghai, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2019 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
XLXiao-Dong Li
Xiao-Dong Li
YZYang Zou
Yang Zou
JPJing Pan
Jing Pan
QLQin-Li Liang
Qin-Li Liang
ZZZan Zeng
Zan Zeng
XZXing-Quan Zhu
Xing-Quan Zhu

1 January 2017 in Mitochondrial DNA Part B
Verified
Journal Article
Open access
ZZZan Zeng
Zan Zeng
JLJinyao Lu
Jinyao Lu
MYMengli Yang
Mengli Yang
HKHui Kang
Hui Kang
LBLi Bo
Li Bo
We sequenced the entire mitochondrial genome of Melanocorypha mongolica for the first time. The mitogenome is 17,358 bp in length, which includes 13 protein-coding genes, 22 tRNA genes, 2 ribosomal RNA (rRNA) genes, the control region (CR1), and the control region 2 (CR2). Gene order follows a pattern similar to those of Eurasian Skylark. Using mitochondrial genomes of Melanocorypha mongolica and other seven reference birds in Sylvioidea, we preformed Bayesian analysis based on concatenated protein-coding genes. The results reveal that Alaudidae and Acroccphalidae are clustered together, which is sister to the branches included Sylviidae and Leiothrichidae. Further sequencing of mitochondrial genomes in Alaudidae is useful to advance phylogenetic relationship of species in the family.

27 September 2019 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
SGShan Gao
Shan Gao
ZZZan Zeng
Zan Zeng
HWHaoNing Wang
HaoNing Wang
FJFekede Regassa Joka
Fekede Regassa Joka
JPJing Pan
Jing Pan
Xiaolong WangXiaolong Wang
Xiaolong Wang

23 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
KZKaiwen Zhao
Kaiwen Zhao
YHYuzhen He
Yuzhen He
RYRenqi Yao
Renqi Yao
SLShuangshuang Li
Shuangshuang Li
LKLingxu Kong
Lingxu Kong
JZJian Zhou
Jian Zhou
Thoracic aortic aneurysm and dissection is one of the most devastating cardiovascular diseases, with limited medical intervention options. This study aims to develop chimeric antigen receptor-engineered CD34+ hematopoietic stem/progenitor cells and evaluate their effects on repairing endothelial cell injuries in a murine model. All animal experiments were performed in male mice. We design a chimeric antigen receptor containing a single-chain variable fragment targeting VCAM-1 and a VEGFA activation domain. A ligand-mediated lipid nanoparticle delivery system was used to engineer circulating CD34+ cells for transient and tunable chimeric antigen receptor expression. In vitro studies show that the engineered cells exhibit improved differentiation, proliferation, migration, adhesion, and tube formation. They successfully restore endothelial function, strengthened cell junctions, suppressed inflammatory response, and blocked disease progression. This study demonstrates that chimeric antigen receptor technique can effectively equip CD34+ hematopoietic stem/progenitor cells to target injured vascular intima, offering a promising approach for treating cardiovascular diseases.